BiotechTube
Home/Atara Biotherapeutics/Cokey Nguyen, Ph.D.
CN

Cokey Nguyen, Ph.D.

President and Chief Executive Officer

Atara Biotherapeutics

Therapeutic Areas

OncologyAutoimmune DiseasesViral Diseases

Atara Biotherapeutics Pipeline

DrugIndicationPhase
EBVALLO (tabelecleucel)EBV+ Post-Transplant Lymphoproliferative Disease (PTLD)Approved (EU)
ATA3219B-cell Non-Hodgkin LymphomaPhase 1
ATA3271Advanced Mesothelioma & NSCLC (PD-L1+)Preclinical
Autoimmune ProgramUndisclosed Autoimmune Disease(s)Discovery

Leadership Team at Atara Biotherapeutics

YG
Yanina Grant-Huerta
Chief Accounting Officer
View full Atara Biotherapeutics profile